SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Amazon.com, Inc. is a multinational technology company, which engages in the provision of online retail shopping services. It operates through the following segments: North America, International, and Amazon Web Services (AWS). The North America segment offers retail sale of consumer products, including from sellers, advertising, and subscriptions services through North America-focused online and physical stores. The International segment focuses on retail sale of consumer products, including sellers, advertising, and subscription services through internationally focused online stores. The AWS segment is composed of global sales of computers, storage, databases, and other services for start-ups, enterprises, government agencies, and academic institutions. The company was founded by Jeffrey P. Bezos in July 1994 and is headquartered in Seattle, WA.

Amazon.com Inc.

Amazon.com Inc

Morgan Stanleys designation of Amazon as a top pick, alongside optimism about AWS growth and AI initiatives such as Trainium, is driving attention. Many traders welcomed the sharp move, while others questioned the rally or discussed taking profits and looking for a pullback.

Disc Medicine, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery, development, and commercialization of treatments for hematologic diseases. It assembles a portfolio of clinical and preclinical product candidates that aim to modify fundamental biological pathways associated with the formation and function of red blood cells, specifically heme biosynthesis and iron homeostasis. The company was founded in October 2017 and is headquartered in Watertown, MA.

Disc Medicine Inc

Disc Medicine is surging after bitopertin met all primary and secondary endpoints in the Phase 3 APOLLO trial for erythropoietic protoporphyria, strengthening the companys path toward an FDA resubmission. Traders are broadly bullish and debating a possible short squeeze, while some cite dizziness concerns and potential profit-taking.

Sea Ltd. is an internet and mobile platform company, which engages in the provision of online gaming services. It operates through the following segments: Digital Entertainment, E-Commerce, and Digital Financial Services. The Digital Entertainment segment offers and develops mobile and PC online games. The E-Commerce segment manages a third-party marketplace through the Shopee mobile app and websites that connect buyers and sellers. The Digital Financial Services segment includes a variety of payment services and loans to individuals and businesses through SeaMoney. Sea was founded by Xiao Dong Li, Gang Ye, and Jing Ye Chen on May 8, 2009 and is headquartered in Singapore.

Sea Ltd - ADR

Sea shares are drawing attention after a sharp slide and technical breakdown, with traders repeatedly pointing to insider share sales as added selling pressure. Some view the sales as planned and the decline as disconnected from the companys growth, while others worry about management confidence and cite broader Southeast Asian market and oil-related risks.

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

IBRX is drawing attention for a sharp selloff despite the FDAs expanded ANKTIVA approval for papillary bladder cancer and encouraging long-term trial data. Traders debate whether the decline reflects sell-the-news profit-taking and broader biotech weakness, while others blame options-related pressure or short selling; concerns about revenue growth and future dilution also surface.

Cleveland-Cliffs, Inc. is a flat-rolled steel company, which engages in provision of iron ore pellets to the North American steel industry. It focuses on the production of metallic and coke, iron making, steelmaking, rolling and finishing, and downstream tubular components, stamping, and tooling. It operates through the Steelmaking and Other Businesses segments. The company was founded in 1847 and is headquartered in Cleveland, OH.

Cleveland-Cliffs Inc

Cleveland-Cliffs stronger-than-guided third-quarter results and upbeat 2027 EBITDA outlook have driven a sharp rally, with traders also pointing to short-covering and higher steel prices. The reaction is divided: bulls see room for continued gains, while skeptics warn the rally could fade and question whether the outlook can overcome the companys debt concerns.

Cerebras Systems, Inc. engages in the designing and provision of processors for artificial intelligence (AI) training and inference. Its products include inference, Wafer Scale Engine, AI supercomputers, AI model services, cloud, systems, and processors. The company was founded by Sean Lie, Andrew D. Feldman, Gary Lauterbach, Michael James, and Jean Philippe Fricker in 2015 and is headquartered in Sunnyvale, CA.

Cerebras Systems Inc - Ordinary Shares - Class A

Cerebras Systems Inc

Cerebras is drawing attention after a steep post-IPO selloff, with traders citing share-unlock and insider-selling pressure, valuation and growth concerns, and broader weakness in AI and semiconductor stocks. Bulls are buying the dip and arguing the decline is overdone, while bears warn that selling could continue.

CoreWeave, Inc. engages in the powers of the creation and delivery of the intelligence that drives innovation. It offers a solution used by organizations of all sizes that require sophisticated AI computing, from the largest of enterprises to small, well-funded start-ups. The company was founded by Michael Intrator, Brian Venturo, Peter Salanki, and Brannin McBee on September 21, 2017 and is headquartered in Livingston, NJ.

CoreWeave Inc. - Ordinary Shares - Class A

CoreWeave Inc

Goldman Sachs upgrade of CoreWeave to Buy after a sharp selloff sparked a rebound attempt, but traders debated whether the call could overcome persistent selling. The main divide is between optimism about AI-compute demand and contracted backlog, and concern that heavy debt and financing costs could threaten the business.

Almonty Industries, Inc. engages in the mining, processing, and shipment of tungsten concentrates. Its projects include Almonty Korea Tungsten, Panasquiera mine, Gentung, Almonty Korea Moly, Los Santos mine, and Valtreixal. The company was founded on September 28, 2009 and is headquartered in Dillon, MT.

Almonty Industries Inc

Almonty is drawing attention after a sharp selloff around its investor day, with traders divided over CEO Lewis Blacks presentation: some found the remarks positive, while others read his delivery as a sign of undisclosed problems. Bullish holders continue to cite the Sangdong production ramp and tungsten-supply outlook, while skeptics are focused on execution and the lack of clear reassurance.

Sunrun, Inc. engages in the design, development, installation, sale, ownership, and maintenance of residential solar energy systems. It sells solar service offerings and installs solar energy systems for homeowners. Customers can access its products through three channels: direct-to-consumer, solar partnerships, and strategic partnerships. The company was founded by Edward Harris Fenster, Robert Nat Kreamer, and Lynn Michelle Jurich in January 2007 and is headquartered in San Francisco, CA.

Sunrun Inc

Sunruns continued share-price decline and heavy short interest dominate the discussion, with traders debating whether rate-sensitive solar-sector pressures and weak guidance outweigh the companys storage, virtual-power-plant, and AI data-center potential. Some see a possible short squeeze or recovery, while others expect further downside.

Alpha Tau Medical Ltd. is a clinical-stage oncology therapeutics company, which focuses on the research, development, and commercialization of diffusing alpha-emitters radiation therapy for the treatment of cancer. The firm is involved in the clinical trials at cancer centers with indications that include skin cancer, oral cavity cancer, breast cancer, and pancreatic cancer. The company was founded by Uzi Sofer, Yona Keisari, and Itzhak Kelson in November 2015 and is headquartered in Jerusalem, Israel.

Alpha Tau Medical Ltd

ALPHA TAU MEDICAL LTD

Attention centers on the FDA-cleared expansion of Alpha Taus REGAIN trial for recurrent glioblastoma and anticipated clinical data at the SNO meeting. Traders are bullish on early tumor-control findings and the broader pipeline, though some note the evidence comes from a small initial cohort.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

NIO Stock Hits Fresh 52-Week Low As Wall Street Slashes Price Targets Citing Slow Demand

Equity

The stock closed the day at $4.06, after hitting a fresh 52-week low of $3.99 during Tuesday’s session. 

Nio Stock Snaps Three-Week Losing Streak On Onvo L80 Debut Priced Below Tesla Model Y

NIO subsidiary Onvo officially launched the L80, a large five-seat family SUV, earlier on Friday. 


NIO Stock Gains After Co Begins Pre-Sales Of Onvo SUV: Retail Sees ‘Sharp’ Jump In Share Price

Nio CEO William Li announced the news in a post on X, positioning the vehicle as a “game-changer” in the large five-seater SUV segment.

NIO Gives Its Model Y Nemesis LiDAR Vision — Wallet-Friendly Price Tag Unchanged

The 2026 model year Onvo L90 starts at RMB 265,800, including the battery, compared to Model YL’s RMB 339,000 sticker price.

NIO Stock Continues Two-Week Rally — How Is ES9 Driving Momentum?

The stock gained over 3% this week, marking its second consecutive week in the green.


Nio Stock Rallies In Anticipation Of Upbeat Q1 Delivery Numbers After America Expansion Efforts

By the end of February this year, the company’s delivery numbers stood at 47,979, exceeding last year’s full quarter numbers with a full month more to go. 

The Iran Storm Bypasses China: Why Its ETFs Look Attractive Now

ETFs like MCHI draw attention as China's retail sales and industrial output beat expectations, signaling renewed economic momentum.

NIO Stock Surged More Than 14% On First Quarterly Profit — How Much More Upside Does Wall Street See?

BofA raised the firm's price target on Nio to $6.70 from $6.30, representing a potential upside of about 36% from the stock’s closing price on Monday. 


Nio Shares Edge Up In Anticipation Of Q4 2025 Earnings Report

Nio is now expected to announce its financial results for the fourth quarter on March 10.


Nio Hits New ES8 Delivery Milestone As It Gears Up To Record First Quarterly Profit From Operations

The 70,000th vehicle was delivered in the Zhejiang province, Nio CEO William Li said in a post on X. 

SPDR Index Shares Funds - State Street SPDR S&P China ETF

Bearish Sentiment

<ul class="summary-bullets"><li>JPMorgan analyst Nick Lai downgraded Nio Inc. to Neutral from Overweight and slashed his price target to $4.50 from $7.</li><li>Lai said the slow demand Nio is seeing outweighs its sustained profitability.</li><li>Citi analyst Jeff Chung kept a Buy rating but lowered his target to $7.10 from $8.20 and reduced 2026-28 volume and revenue estimates.</li></ul><p>Shares of Chinese EV maker Nio Inc. (NIO) closed down 4% on Tuesday after the company reported a third straight quarter of adjusted operating profit, revenue that missed its own prior ranges, and a third-quarter outlook indicating only modest sequential growth, spurring Wall Street price cuts and downgrades.</p><p>The stock closed the day at $4.06, after hitting a fresh 52-week low of $3.99 during Tuesday’s session.</p><h2 class="st-heading-2">Analysts Split On Profitability Versus Demand</h2><p>JPMorgan analyst Nick Lai downgraded Nio Inc. to Neutral from Overweight and slashed his price target to $4.50 from $7. Citi analyst Jeff Chung kept a Buy rating but lowered his target to $7.10 from $8.20 and reduced 2026-28 volume and revenue estimates.</p><p>Lai said the slow demand Nio is seeing outweighs its sustained profitability. JPMorgan likes the company’s profitability despite cost inflation, but said management’s “lukewarm anticipation” on vehicle delivery in the second half of 2026 shows the challenges facing the broader passenger-vehicle market in China. Sluggish demand and a difficult pricing environment will weigh on Nio, the firm said.</p><p>Chung, meanwhile, kept a Buy rating after the report but cut volume and revenue estimates for 2026 through 2028 and reduced the price target accordingly.</p><h2 class="st-heading-2">Near-Term Outlook Stays Modest After Soft July And August</h2><p>Nio guided third-quarter deliveries of 108,000 to 111,000 vehicles, up 24% to 27.5% from a year earlier, but only marginally higher than Q2 delivery numbers, and revenue of RMB33.29 billion to RMB34.05 billion.</p><p>Nio’s July deliveries were 35,934 and August deliveries were 35,836. Founder, Chairman and Chief Executive William Li said all three brands grew both sales volume and average transaction price in the second quarter.</p><h2 class="st-heading-2">Q2: Sales Rise, Guidance Missed</h2><p>Nio delivered 107,658 vehicles in the quarter ended June 30, up 49.4% from a year earlier and 29% from the first quarter. That fell short of prior guidance of 110,000 to 115,000.</p><p>Total revenue rose 69.1% to RMB32.14 billion ($4.74 billion), below the previous guided range of RMB32.78 billion to RMB34.44 billion. Vehicle sales were RMB29.06 billion, up 80.1%.</p><p>Vehicle gross margin was 18.5%, compared with 10.3% a year earlier and 18.8% in the first quarter. Overall gross margin was 18.4%. Adjusted and diluted earnings came in at RMB0.01 per ADS, compared with Wall Street expectations for a loss of RMB0.30 per ADS. Cash, restricted cash and investments totaled RMB56.7 billion as of June 30.</p><h2 class="st-heading-2">How Did NIO Retail Traders React?</h2><p>On Stocktwits, retail sentiment around NIO rose from ‘bullish’ to ‘extremely bullish’ over the past 24 hours, while message volume remained ‘high.’</p><p>A Stocktwits user opined that the company should buy back shares using its remaining cash balance to boost the stock.</p><p><stembedurl>https://stocktwits.com/HonestJoe/message/663391051</stembedurl></p><p>Another user noted that the company did beat expectations on several metrics.</p><p><stembedurl>https://stocktwits.com/Poofi3/message/663365850</stembedurl></p><p>U.S.-listed shares of <a href="https://stocktwits.com/symbol/NIO">NIO</a> have fallen 20% year-to-date.&nbsp;</p><p>Read More: <a href="https://stocktwits.com/news-articles/markets/equity/mdb-stock-dives-after-hours-despite-raised-full-year-forecast-what-s-driving-the-selloff/cZsoy15RJMu">MDB Stock Dives After-Hours Despite Raised Full-Year Forecast — What’s Driving The Selloff?</a></p><p><i>For updates and corrections, email newsroom[at]stocktwits[dot]com.</i></p>

Customers view the NIO ES9 model displayed within a NIO showroom in Shanghai, China, on July 12, 2026. (Photo by Costfoto/NurPhoto via Getty Images)

SPDR S&P China ETF

NIO Inc

SPDR Portfolio Emerging Markets ETF

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Current Price	$83.99
Prev Close	$84.04
Open	$84.22
Dividend Yield	N/A
50-Day Moving Average	$88.60
Beta	N/A
Avg. Volume	27,977.59
PE Ratio	N/A

52-Week High	$105.00
52-Week Low	$83.91
Market Capitalization	N/A
EPS (Annual)	N/A
Price to Book	N/A
Revenue Per Employee	N/A

Feed

News

Sentiment

Fundamentals

Info

GXC Fundamentals